Margaret Karow News Today : Breaking News, Live Updates & Top Stories | Vimarsana

How Tentarix s US$35m capital raise is set to boost business for Vancouver s ITS

How Tentarix s US$35m capital raise is set to boost business for Vancouver s ITS
newwestrecord.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newwestrecord.ca Daily Mail and Mail on Sunday newspapers.

British columbiaUnited statesUnited kingdomPaul kangStephen demarestMargaret karowMichael galloAbgenix biopharmaPaul graysonUniversity of british columbiaZymeworks incGilead sciences incVancouver innovative targetting solutionsInnovative targetting solutionsVirtual wayAmplitude ventures

How Tentarix s US$35m capital raise is set to boost business for Vancouver s ITS

Vancouver's Innovative Targeting Solutions partners with San-Diego-based Tentarix to make drugs

British columbiaUnited statesUnited kingdomPaul graysonMichael galloMargaret karowAbgenix biopharmaStephen demarestPaul kangUniversity of british columbiaZymeworks incGilead sciences incVancouver innovative targetting solutionsInnovative targetting solutionsVirtual wayAmplitude ventures

B C -founded biologics developer Tentarix raises US$35-million after securing Gilead deal

Tentarix is developing biologic therapies that target specific cells in the body and could be used to fight cancer and autoimmune diseases while limiting side effects

San franciscoUnited statesSan diegoMargaret karowAllyson tighePaul kangPaul graysonStephen demarestMichael galloInnovative targeting solutions incTentarix biotherapeutics incCell genesys incAmgen incGilead sciences incLog increate freeGilead sciences

How Tentarix s US$35m capital raise is set to boost business for Vancouver s ITS

Vancouver's Innovative Targeting Solutions partners with San-Diego-based Tentarix to make drugs

United statesBritish columbiaUnited kingdomMichael galloAbgenix biopharmaPaul kangStephen demarestMargaret karowPaul graysonZymeworks incGilead sciences incVancouver innovative targetting solutionsUniversity of british columbiaInnovative targetting solutionsVirtual wayAmplitude ventures

Gilead inks deal with biologics developer Tentarix co-founded by BC entrepreneurs

The U.S. drug giant will pay Tentarix Biotherapeutics Inc. US$66-million upfront and the pair will partner on three development programs

San franciscoUnited statesSan diegoBritish columbiaFlavius martinStephen demarestJerel davisMichael galloMargaret karowPaul kangPaul graysonCell genesys incZymeworks incTentarix biotherapeutics incGilead sciences incAbcellera biologics inc